Healthcare -
Biotechnology - NASDAQ - US
$ 465.0
6.07 %
$ 120 B
Market Cap
-244.74
P/E
VRTX - COST OF REVENUE
Cost of Revenue VRTX - Vertex Pharmaceuticals Incorporated
1.26 B
LAST VALUE
18.15%
2 YEAR CAGR
25.25%
5 YEAR CAGR
25.49%
10 YEAR CAGR